Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
433 studies found for:    "Thyroid Neoplasms"
Show Display Options
Rank Status Study
1 Terminated Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer
Conditions: Thyroid Neoplasm;   Thyroid Carcinoma;   Medullary Carcinoma
Intervention: Other: 18F-L-DOPA PET
2 Completed Biomarkers to Distinguish Benign From Malignant Thyroid Neoplasm
Conditions: Cancer of the Thyroid;   Neoplasms, Thyroid;   Thyroid Adenoma;   Thyroid Cancer;   Thyroid Carcinoma
3 Unknown  Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer
Conditions: Thyroid Neoplasms;   Carcinoma;   Thyroid Cancer;   Metastatic Cancer
Intervention: Drug: Bevacizumab
4 Completed The Role of an Optical Probe in Thyroid Cancer Diagnosis: Pilot Study
Conditions: Thyroid Nodule;   Thyroid Neoplasms;   Thyroid Cancer
5 Recruiting Sentinel Lymphnode in Patients With Papillary Thyroid Carcinoma and in Patients With Suspected Thyroid Neoplasia
Conditions: Thyroid Neoplasms;   Thyroid Cancer
Intervention: Procedure: Histological investigation of the SN
6 Unknown  PET Evaluation of Recurrent Differentiated Thyroid Cancer
Conditions: Thyroid Neoplasms;   Differentiated Thyroid Cancer
7 Completed
Has Results
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
Conditions: Insular Thyroid Cancer;   Recurrent Thyroid Cancer;   Stage II Follicular Thyroid Cancer;   Stage II Papillary Thyroid Cancer;   Stage IV Follicular Thyroid Cancer;   Stage IV Papillary Thyroid Cancer
Intervention: Drug: Bortezomib
8 Completed Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer
Conditions: Metastatic Differentiated Thyroid Cancer;   Metastatic Poorly Differentiated Thyroid Cancer;   Metastatic Anaplastic Thyroid Cancer;   Metastatic Medullary Thyroid Cancer
Intervention: Drug: sorafenib
9 Active, not recruiting Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
Conditions: Follicular Thyroid Cancer;   Insular Thyroid Cancer;   Papillary Thyroid Cancer;   Recurrent Thyroid Cancer
Interventions: Drug: dabrafenib;   Drug: trametinib;   Other: Correlative Studies
10 Completed Sutent Adjunctive Treatment of Differentiated Thyroid Cancer
Conditions: Papillary Thyroid Cancer;   Follicular Thyroid Cancer;   Differentiated Thyroid Cancer
Intervention: Drug: SU011248, Sutent
11 Enrolling by invitation Tri-modal Imaging Instrument for Thyroid Cancer
Conditions: Thyroid Neoplasms;   Thyroid Cancer;   Thyroid Nodule
Intervention: Device: Tri-modal imaging
12 Recruiting A Phase II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer
Conditions: Anaplastic Thyroid Cancer;   Thyroid Cancer
Intervention: Drug: MLN0128
13 Suspended Pre-Operative Nodal Staging of Thyroid Cancer Using Ultra-Small Superparamagnetic Iron Oxide Magnetic Resonance Imaging (USPIO MRI): Preliminary Study
Conditions: Papillary Carcinoma of Thyroid Metastatic to Regional Lymph Node;   Metastatic Medullary Thyroid Cancer;   Follicular Thyroid Cancer Lymph Node Metastasis
Interventions: Drug: Ferumoxytol;   Device: lymphotrophic superparamagnetic nanoparticles (LSN MRI).
14 Terminated Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer
Conditions: Anaplastic Thyroid Cancer;   Insular Thyroid Cancer;   Recurrent Thyroid Cancer;   Stage III Follicular Thyroid Cancer;   Stage III Papillary Thyroid Cancer;   Stage IV Follicular Thyroid Cancer;   Stage IV Papillary Thyroid Cancer
Interventions: Drug: sorafenib tosylate;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Radiation: fludeoxyglucose F 18;   Procedure: positron emission tomography;   Procedure: dynamic contrast-enhanced magnetic resonance imaging
15 Completed
Has Results
Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer
Conditions: Thyroid Cancer;   Differentiated Thyroid Carcinoma
Interventions: Drug: Lithium Carbonate;   Drug: Placebo
16 Completed Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer.
Condition: Thyroid Neoplasms
Intervention: Procedure: IMRT
17 Recruiting An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT)
Conditions: Thyroid Neoplasms;   Head and Neck Neoplasms
Interventions: Drug: C-PERT;   Drug: G-PERT
18 Active, not recruiting Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer
Conditions: Recurrent Thyroid Gland Carcinoma;   Stage III Differentiated Thyroid Gland Carcinoma;   Stage III Thyroid Gland Medullary Carcinoma;   Stage IVA Differentiated Thyroid Gland Carcinoma;   Stage IVA Thyroid Gland Medullary Carcinoma;   Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;   Stage IVB Differentiated Thyroid Gland Carcinoma;   Stage IVB Thyroid Gland Medullary Carcinoma;   Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;   Stage IVC Differentiated Thyroid Gland Carcinoma;   Stage IVC Thyroid Gland Medullary Carcinoma;   Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma;   Thyroid Gland Undifferentiated (Anaplastic) Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Pazopanib Hydrochloride
19 Recruiting Studies on Tumors of the Thyroid
Conditions: Hurthle Cell Thyroid Cancer;   Tall Cell Variant Thyroid Cancer;   Follicular Thyroid Cancer;   Thyroid Cancer;   Papillary Thyroid Cancer
20 Completed Multicenter Study Differentiated Thyroid Carcinoma
Condition: Thyroid Neoplasms
Intervention: Procedure: external beam radiotherapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years